3 results
Approved WMOCompleted
To evaluate the safety and efficacy of abicipar (2 mg), compared to 0.5 mg ranibizumab in treatment-naïve patients with neovascular AMD.
Approved WMOCompleted
Primary* To confirm the efficacy of OTL38 in combination with fluorescent light to detect additional Folate Receptor-positive (FR+) ovarian cancer lesions not detected by palpation and visualization under normal light in patients with FR+ ovarian…
Approved WMOCompleted
The purpose of this study is to evaluate the feasibility of postoperative home monitoring for patients undergoing outpatient knee- or hip arthroplasty; discharged on the same day as surgery; less than 12-hour hospital stay.We hypothesise that a…